Understanding the Chemotherapy Drug Durvalumab 認識化療藥品Durvalumab
2025/11/21
Durvalumab is a PD-L1 immune checkpoint inhibitor and a monoclonal antibody. It works by enhancing the body’s own immune system to increase its ability to fight tumors, thereby achieving a therapeutic effect. Clinically, it can be used alone or in combination with other drugs to treat non-small cell lung cancer, small cell lung cancer, biliary tract cancer, and hepatocellular carcinoma.